CoChat

Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer

Open access
Thakur, Archana, Rahman, KM Wahidur, Wu, Jack, Bollig, Aliccia, Biliran, Hector, Lin, Xiukun, Nassar, Hind, Grignon, David J., Sarkar, Fazlul H., Liao, Joshua D. · 2007 · Molecular Cancer Research
Cited by 83

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The consequence of activation status or gain/loss of an X-chromosome in terms of the expression of tumor suppressor genes or oncogenes in breast cancer has not been clearly addressed. In this study, we investigated the activation status of the X-chromosomes in a panel of human breast cancer cell lines, human breast carcinoma, and adjacent mammary tissues and a panel of murine mammary epithelial sublines ranging from low to high invasive potentials. Results show that most human breast cancer cell lines were homozygous, but both benign cell lines were heterozygous for highly polymorphic X-loci (IDS and G6PD). On the other hand, 60% of human breast carcinoma cases were heterozygous for either IDS or G6PD markers. Investigation of the activation status of heterozygous cell lines revealed the presence of only one active X-chromosome, whereas most heterozygous human breast carcinoma cases had two active X-chromosomes. Furthermore, we determined whether or not an additional active X-chromosome affects expression levels of tumor suppressor genes and oncogenes. Reverse transcription-PCR data show high expression of putative tumor suppressor genes Rsk4 and RbAp46 in 47% and 79% of breast carcinoma cases, respectively, whereas Cldn2 was down-regulated in 52% of breast cancer cases compared with normal adjacent tissues. Consistent with mRNA expression, immunostaining for these proteins also showed a similar pattern. In conclusion, our data suggest that high expression of RbAp46 is likely to have a role in the development or progression of human breast cancer. The activation status of the X-chromosome may influence the expression levels of X-linked oncogenes or tumor suppressor genes. (Mol Cancer Res 2007;5(2):171–81)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-06-0071

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Gene Action in the X-chromosome of the Mouse (Mus musculus L.)

    LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 2×

    “(Mol Cancer Res 2007;5(2):171–81) Introduction In female mammalian cells, one of the two X-chromosomes is inactivated during a short window of embryonic life through heritable epigenetic modifications, thus achieving dosage compensation with males who have one active X-chromosome and a sex-determining Y-chromosome (1,…”
    Background

Show all 1 references

Cited by

See all 83

Metadata

Authors
Thakur, A., Rahman, K. W., Wu, J., Bollig, A., Biliran, H., Lin, X., Nassar, H., Grignon, D. J., Sarkar, F. H., & Liao, J. D.
Venue
Molecular Cancer Research
Published
2007-02-01
Volume
5
Issue
2
Pages
171-181
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2136469817
Cited by
83
References
1
FWCI
2.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-06-0071
The paper
Thakur, A., Rahman, K. W., Wu, J., Bollig, A., Biliran, H., Lin, X., Nassar, H., Grignon, D. J., Sarkar, F. H., & Liao, J. D. (2007). Aberrant Expression of X-Linked Genes RbAp46, Rsk4, and Cldn2 in Breast Cancer. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-06-0071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.